Related references
Note: Only part of the references are listed.Pancytopenia and Profound Neutropenia as a Sequela of Severe SARS-CoV-2 Infection (COVID-19) With Concern for Bone Marrow Involvement
Jarelys M. Hernandez et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Mechanism of thrombocytopenia in COVID-19 patients
Panyang Xu et al.
ANNALS OF HEMATOLOGY (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
Ashley Barlow et al.
PHARMACOTHERAPY (2020)
First case of persistent pancytopenia associated with SARS-CoV-2 bone marrow infiltration in an immunocompromised patient
N. Issa et al.
ANNALS OF ONCOLOGY (2020)
Can COVID-19 cause severe neutropenia?
Patricia Lopez-Pereira et al.
CLINICAL CASE REPORTS (2020)
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents
Delia Bishara et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
Severe neutropenia: a diagnostic approach
HG Munshi et al.
WESTERN JOURNAL OF MEDICINE (2000)
Share Paper
